BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 22484467)

  • 1. HPV DNA, E6*I-mRNA expression and p16INK4A immunohistochemistry in head and neck cancer - how valid is p16INK4A as surrogate marker?
    Hoffmann M; Tribius S; Quabius ES; Henry H; Pfannenschmidt S; Burkhardt C; Görögh T; Halec G; Hoffmann AS; Kahn T; Röcken C; Haag J; Waterboer T; Schmitt M
    Cancer Lett; 2012 Oct; 323(1):88-96. PubMed ID: 22484467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinoma.
    Deng Z; Hasegawa M; Aoki K; Matayoshi S; Kiyuna A; Yamashita Y; Uehara T; Agena S; Maeda H; Xie M; Suzuki M
    Int J Oncol; 2014 Jul; 45(1):67-76. PubMed ID: 24820457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
    Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
    Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p16(INK4a) /Ki-67 co-expression specifically identifies transformed cells in the head and neck region.
    Prigge ES; Toth C; Dyckhoff G; Wagner S; Müller F; Wittekindt C; Freier K; Plinkert P; Hoffmann J; Vinokurova S; Klussmann JP; von Knebel Doeberitz M; Reuschenbach M
    Int J Cancer; 2015 Apr; 136(7):1589-99. PubMed ID: 25104331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p16(INK4a) overexpression predicts translational active human papillomavirus infection in tonsillar cancer.
    Hoffmann M; Ihloff AS; Görögh T; Weise JB; Fazel A; Krams M; Rittgen W; Schwarz E; Kahn T
    Int J Cancer; 2010 Oct; 127(7):1595-602. PubMed ID: 20091864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of p16(INK4a) /Ki67 immunocytology and HPV polymerase chain reaction for the noninvasive analysis of HPV involvement in head and neck cancer.
    Linxweiler M; Bochen F; Wemmert S; Lerner C; Hasenfus A; Bohle RM; Al-Kadah B; Takacs ZF; Smola S; Schick B
    Cancer Cytopathol; 2015 Apr; 123(4):219-29. PubMed ID: 25557267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of HPV expression in laryngeal squamous cell carcinoma.
    Gheit T; Abedi-Ardekani B; Carreira C; Missad CG; Tommasino M; Torrente MC
    J Med Virol; 2014 Apr; 86(4):642-6. PubMed ID: 24374907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method.
    Bishop JA; Ma XJ; Wang H; Luo Y; Illei PB; Begum S; Taube JM; Koch WM; Westra WH
    Am J Surg Pathol; 2012 Dec; 36(12):1874-82. PubMed ID: 23060353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers of HPV in head and neck squamous cell carcinoma.
    Liang C; Marsit CJ; McClean MD; Nelson HH; Christensen BC; Haddad RI; Clark JR; Wein RO; Grillone GA; Houseman EA; Halec G; Waterboer T; Pawlita M; Krane JF; Kelsey KT
    Cancer Res; 2012 Oct; 72(19):5004-13. PubMed ID: 22991304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double positivity for HPV DNA/p16 in tonsillar and base of tongue cancer improves prognostication: Insights from a large population-based study.
    Garnaes E; Frederiksen K; Kiss K; Andersen L; Therkildsen MH; Franzmann MB; Specht L; Andersen E; Norrild B; Kjaer SK; von Buchwald C
    Int J Cancer; 2016 Dec; 139(11):2598-605. PubMed ID: 27537425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma.
    Young RJ; Urban D; Angel C; Corry J; Lyons B; Vallance N; Kleid S; Iseli TA; Solomon B; Rischin D
    Br J Cancer; 2015 Mar; 112(6):1098-104. PubMed ID: 25688737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verrucous carcinomas of the head and neck, including those with associated squamous cell carcinoma, lack transcriptionally active high-risk human papillomavirus.
    Patel KR; Chernock RD; Zhang TR; Wang X; El-Mofty SK; Lewis JS
    Hum Pathol; 2013 Nov; 44(11):2385-92. PubMed ID: 24071016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of HPV-status on survival of patients with tonsillar carcinomas (TSCC) treated by CO
    Hoffmann M; Quabius ES; Tribius S; Gebhardt S; Görögh T; Hedderich J; Huber K; Dunst J; Ambrosch P
    Cancer Lett; 2018 Jan; 413():59-68. PubMed ID: 29100961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is p16 immunohistochemistry a more cost-effective method for identification of human papilloma virus-associated head and neck squamous cell carcinoma?
    Thomas J; Primeaux T
    Ann Diagn Pathol; 2012 Apr; 16(2):91-9. PubMed ID: 22197546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P16(INK4a) correlates to human papillomavirus presence, response to radiotherapy and clinical outcome in tonsillar carcinoma.
    Mellin Dahlstrand H; Lindquist D; Björnestål L; Ohlsson A; Dalianis T; Munck-Wikland E; Elmberger G
    Anticancer Res; 2005; 25(6C):4375-83. PubMed ID: 16334111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The presence of high-risk human papillomavirus (HPV) E6/E7 mRNA transcripts in a subset of sinonasal carcinomas is evidence of involvement of HPV in its etiopathogenesis.
    Laco J; Sieglová K; Vošmiková H; Dundr P; Němejcová K; Michálek J; Čelakovský P; Chrobok V; Mottl R; Mottlová A; Tuček L; Slezák R; Chmelařová M; Sirák I; Vošmik M; Ryška A
    Virchows Arch; 2015 Oct; 467(4):405-15. PubMed ID: 26229021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study to compare the detection of HPV-16 biomarkers in salivary oral rinses with tumour p16(INK4a) expression in head and neck squamous cell carcinoma patients.
    Chai RC; Lim Y; Frazer IH; Wan Y; Perry C; Jones L; Lambie D; Punyadeera C
    BMC Cancer; 2016 Mar; 16():178. PubMed ID: 26940728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus.
    Klussmann JP; Gültekin E; Weissenborn SJ; Wieland U; Dries V; Dienes HP; Eckel HE; Pfister HJ; Fuchs PG
    Am J Pathol; 2003 Mar; 162(3):747-53. PubMed ID: 12598309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8.
    Hafkamp HC; Speel EJ; Haesevoets A; Bot FJ; Dinjens WN; Ramaekers FC; Hopman AH; Manni JJ
    Int J Cancer; 2003 Nov; 107(3):394-400. PubMed ID: 14506739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus status in young patients with head and neck squamous cell carcinoma.
    van Monsjou HS; van Velthuysen ML; van den Brekel MW; Jordanova ES; Melief CJ; Balm AJ
    Int J Cancer; 2012 Apr; 130(8):1806-12. PubMed ID: 21607949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.